Sanofi-Aventis (France) Loses Again in Bid to Keep Generic Plavix Off German Market

Sanofi-Aventis and partner Bristol-Myers Squibb have sufferd a new setback in their bid to reduce the damage caused by the sale in Germany of a generic version of their blockbuster blood thinner Plavix.